SCHEMBL20041979

SCHEMBL20041979

O=Cc1cc(F)c(C2CNC(=O)C2)c(F)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 13/20 0.37
PDE4B Q07343 7/20 0.37
PDE4C Q08493 7/20 0.37
PDE4D Q08499 7/20 0.37
ALDH1A1 P00352 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 1/20 0.37
MTNR1A P48039 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.34
TSHR P16473 1/20 0.34
PKM P14618 1/20 0.32
CYP3A4 P08684 2/20 0.32
VEGFA P15692 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32
ALOX15 P16050 1/20 0.32
CREBBP Q92793 1/20 0.32
KDM4E B2RXH2 1/20 0.32
PDE5A O76074 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20177585 0.83 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL18590497 0.80 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL20177816 0.80 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL20177572 0.80 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL19559475 0.80 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL23653985 0.80 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL18590506 0.80 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL20177503 0.80 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL19559435 0.76 FPR1 (0.47) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL19559386 0.76 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305763-A1 DEUTERATED OR ISOTOPICALLY LABELED UREA DERIVATIVES OR PHARMACOLOGICALLY ACCEPTABLE SALTS THEREOF USEFUL AS FPRL-1 AGONISTS Kyorin Pharmaceutical Co., Ltd. (JP) 2018-04-11 EP disclosed